Elan Corporation PLC
Treasury Building
Lower Grand Canal Street
Dublin
2
Tel: 353-1-709-4000
Fax: 353-1-709-4700
Website: http://www.elan.ie/
Email: epo@elancorp.com
437 articles about Elan Corporation PLC
-
Perrigo Company Files Registration Statement on Form S-4 in Connection with Proposed Acquisition of Elan Corporation PLC
8/28/2013
-
Elan Corporation PLC Hands Victory to Perrigo Company After Brutal Battle
8/12/2013
-
Perrigo Company Takeover: is Elan Corporation PLC Acquisition Part of a New Irish Pharma Investment Drive?
7/31/2013
-
Perrigo Shells Out $8.6 Billion for Elan
7/29/2013
-
FDA Grant Fast Track Designation to Elan Corporation PLC's ELND005 for the Treatment of Neuropsychiatric Symptoms in Alzheimer’s Disease
7/17/2013
-
Elan Corporation PLC Announces Webcast of Second Quarter 2013 Financial Results
7/11/2013
-
Game May Not be Over for Royalty Pharma's Bid for Elan Corporation PLC
6/28/2013
-
BioPharm Executive: Here's to Elan Corporation PLC: Is it a Toast or a Wake?
6/26/2013
-
Theravance, Inc. CEO: The Elan Corporation PLC Vote Doesn't Mean Much
6/21/2013
-
Forest Laboratories, Inc. Mulls Bid for Elan Corporation PLC - Sources
6/20/2013
-
Royalty Pharma Drops Hostile Bid for Elan Corporation PLC
6/18/2013
-
Royalty Pharma Informs Elan Corporation PLC Stockholders About the Consequences Arising From the Results of the Elan EGM Earlier Today
6/17/2013
-
Royalty Pharma Hostile Bid for Elan Corporation PLC in Doubt After Vote
6/17/2013
-
Royalty Pharma Chairman Writes Open Letter to Elan Corporation PLC Board
6/17/2013
-
Royalty Pharma Notes Elan Corporation PLC Sales Process Offers Shareholders No Certainty
6/14/2013
-
Johnson & Johnson Sells Final Stake in Elan Corporation PLC for $332 Million
6/14/2013
-
Elan Corporation PLC Puts Itself Up for Sale
6/14/2013
-
Elan Corporation PLC ADS Holders Decisively Vote Against Theravance, Inc. And AOP Transactions
6/14/2013
-
Elan Corporation PLC Boss Martin Faces Ownership Showdown, Elan Risks Losing $2 Billion if Royalty Pharma Walks
6/13/2013
-
Elan Corporation PLC Board Rejects $6.7 Billion Royalty Pharma Offer
6/11/2013